Vise Technologies Inc. Buys Shares of 6,585 Encompass Health Corporation $EHC

Vise Technologies Inc. purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 6,585 shares of the company’s stock, valued at approximately $808,000.

Other institutional investors have also added to or reduced their stakes in the company. ProShare Advisors LLC grew its holdings in shares of Encompass Health by 4.1% during the 2nd quarter. ProShare Advisors LLC now owns 4,469 shares of the company’s stock valued at $548,000 after purchasing an additional 177 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Encompass Health by 207.1% in the 2nd quarter. Acadian Asset Management LLC now owns 107,929 shares of the company’s stock valued at $13,226,000 after purchasing an additional 72,781 shares during the last quarter. Campbell & CO Investment Adviser LLC boosted its position in Encompass Health by 16.1% in the second quarter. Campbell & CO Investment Adviser LLC now owns 23,437 shares of the company’s stock valued at $2,874,000 after buying an additional 3,246 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Encompass Health during the second quarter worth $306,000. Finally, Parkside Financial Bank & Trust lifted its stake in shares of Encompass Health by 179.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after acquiring an additional 307 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on EHC. UBS Group boosted their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Zacks Research upgraded shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. KeyCorp increased their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Finally, Barclays increased their price target on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Three analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $142.86.

Encompass Health Trading Down 0.4%

NYSE EHC opened at $114.32 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.99. The business has a 50 day moving average price of $122.88 and a 200-day moving average price of $119.68. The company has a market cap of $11.50 billion, a price-to-earnings ratio of 21.61, a P/E/G ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.